1,002
Views
5
CrossRef citations to date
0
Altmetric
Letters

Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance

ORCID Icon, ORCID Icon, &
Pages 4112-4114 | Received 19 May 2021, Accepted 12 Jun 2021, Published online: 01 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elsa Izquierdo-Garcia, Elena Alba Alvaro Alonso, Berta Montero Pastor, Ana Such Díaz & Ismael Escobar Rodríguez. (2022) Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance’. Human Vaccines & Immunotherapeutics 18:5.
Read now
Rebeca Saborido-Fiaño, Nazareth Martinón-Torres, Vanesa Crujeiras-Martinez, Maria Luz Couce & Rosaura Leis. (2021) Reply letter to “safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance”. Human Vaccines & Immunotherapeutics 17:11, pages 4115-4116.
Read now

Articles from other publishers (3)

Jessica Anindita, Hiroki Tanaka, Ryotaro Oyama, Shinya Hagiwara, Daiki Shirane, Sakura Taneichi, Yuta Nakai, Kota Tange, Hiroto Hatakeyama, Yu Sakurai & Hidetaka Akita. (2023) Development of a Ready-to-Use-Type RNA Vaccine Carrier Based on an Intracellular Environment-Responsive Lipid-like Material with Immune-Activating Vitamin E Scaffolds. Pharmaceutics 15:12, pages 2702.
Crossref
Barbara C.F. Ramos, Carolina S. Aranda, Rita S.B. Cardona, Ana Maria Martins, Dirceu Solé, Sue Ann C. Clemens & Ralf Clemens. (2023) Vaccination strategies for people living with inborn errors of metabolism in Brazil. Jornal de Pediatria 99, pages S70-S80.
Crossref
Sumit Kumar Singh & Moinak Sen Sarma. (2022) Hereditary fructose intolerance: A comprehensive review. World Journal of Clinical Pediatrics 11:4, pages 321-329.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.